LEPTOSPIROSIS: EPIDEMIOLOGI, MIKROBIOLOGI, DAN MANAJEMEN KLINIS

Penulis

Dr.dr. Dewa Ayu Putri Sri Masyeni, SpPD, KPTI, FINASIM
Universitas Warmadewa image/svg+xml

Kata Kunci:

LEPTOSPIROSIS, EPIDEMIOLOGI, MIKROBIOLOGI

Sinopsis

Buku ini menyajikan informasi komprehensif mengenai leptospirosis, sebuah penyakit zoonosis yang disebabkan oleh infeksi bakteri Leptospira spp.. Dengan meningkatnya insiden leptospirosis di berbagai belahan dunia, terutama di daerah tropis dan subtropis, buku ini menjadi sumber penting bagi para profesional kesehatan, mahasiswa kedokteran, dan peneliti yang tertarik dalam bidang penyakit infeksi.

Isi Buku:

  • Epidemiologi Leptospirosis: Buku ini mengulas sejarah penemuan leptospirosis, serta distribusi geografis dan faktor risiko yang mempengaruhi penyebaran penyakit ini. Pembaca akan mendapatkan pemahaman yang mendalam tentang bagaimana kondisi lingkungan, sanitasi yang buruk, dan paparan terhadap hewan terinfeksi dapat berkontribusi terhadap kejadian leptospirosis.
  • Mikrobiologi dan Patogenesis: Dalam bagian ini, buku menjelaskan karakteristik bakteri Leptospira, termasuk klasifikasi, morfologi, dan mekanisme penghindaran sistem imun. Pembaca akan diperkenalkan pada aspek mikroskopis dari bakteri ini serta bagaimana mereka berinteraksi dengan inang dan menyebabkan penyakit.
  • Manifestasi Klinis dan Diagnosis: Buku ini membahas berbagai manifestasi klinis dari leptospirosis, mulai dari gejala ringan hingga berat, serta tantangan dalam diagnosis penyakit ini. Penekanan diberikan pada pentingnya pengenalan dini gejala dan penggunaan metode diagnostik yang tepat.
  • Manajemen Klinis dan Terapi: Di sini, pembaca akan menemukan panduan tentang pengobatan leptospirosis, termasuk pilihan antibiotik yang efektif, perawatan suportif, dan manajemen komplikasi. Buku ini juga menyoroti pentingnya edukasi pasien dan upaya pencegahan untuk mengurangi insiden penyakit ini.
  • Peran Mikrobiota Usus: Buku ini mengeksplorasi hubungan antara mikrobiota usus dan keparahan leptospirosis, serta bagaimana keseimbangan mikrobiota dapat mempengaruhi respons imun dan perjalanan penyakit.

Dengan pendekatan yang sistematis dan berbasis bukti, buku ini bertujuan untuk memberikan pemahaman yang lebih baik tentang leptospirosis dan mendorong langkah-langkah pencegahan serta pengendalian yang efektif. Dengan demikian, diharapkan buku ini dapat berkontribusi pada peningkatan kesehatan masyarakat dan pengurangan beban penyakit leptospirosis di seluruh dunia.

Buku ini merupakan sumber daya yang berharga bagi siapapun yang terlibat dalam penanganan dan penelitian leptospirosis, serta bagi mereka yang peduli dengan kesehatan masyarakat secara keseluruhan

Bab

  • KATA PENGANTAR
  • DAFTAR ISI
  • BAB 01 PENDAHULUAN
  • BAB 02 MIKROBIOLOGI & IMUNOLOGI
  • BAB 03 MANIFESTASI KLINIS
  • BAB 04 PENDEKATAN DIAGNOSIS INFEKSI LEPTOSPIRA
  • BAB 05 MANAGEMEN LEPTOSPIROSIS
  • BAB 06 PENUTUP
  • DAFTAR PUSTAKA
  • PROFIL PENULIS

Unduhan

Data unduhan belum tersedia.

Biografi Penulis

Dr.dr. Dewa Ayu Putri Sri Masyeni, SpPD, KPTI, FINASIM, Universitas Warmadewa

Buku ini ditulis oleh Dr. Dewa Ayu Putri Sri Masyeni, SpPD., KPTI., seorang dosen di Fakultas Kedokteran dan Ilmu Kesehatan Universitas Warmadewa, Bali. Beliau merupakan seorang klinisi yang ahli di bidang Ilmu Penyakit Dalam, dengan fokus khusus pada Penyakit Tropis dan Infeksi.

Pendidikan dan Karir

·         Gelar: Dr. dr. Dewa Ayu Putri Sri Masyeni menyelesaikan pendidikan kedokteran dan spesialisasi di bidang Penyakit Dalam, serta mendapatkan sertifikasi dalam Kedokteran Tropis dan Infeksi.

·         Pengalaman Klinis: Beliau memiliki pengalaman luas sebagai praktisi klinis, menangani berbagai kasus penyakit tropis dan infeksi, serta memberikan penanganan medis yang berkualitas kepada pasien.

Karya Ilmiah dan Publikasi

·         Publikasi: Sejak tahun 2017 hingga Desember 2025, beliau telah menerbitkan lebih dari 55 karya ilmiah di jurnal internasional bereputasi yang terindeks Scopus, serta banyak artikel di jurnal terakreditasi Sinta.

·         Buku Ajar: Selain publikasi ilmiah, Dr. Dewa Ayu juga telah menyusun beberapa buku ajar yang digunakan oleh mahasiswa kedokteran, berkontribusi dalam pendidikan medis di Indonesia.

 

 

Aktivitas Penelitian dan Hibah

·         Travel Medicine: Beliau aktif dalam bidang kedokteran wisata (travel medicine) dan telah menulis banyak artikel serta hasil riset di bidang ini.

·         Hibah Penelitian: Dr. Dewa Ayu telah memperoleh berbagai hibah, termasuk hibah nasional dari Kementerian Pendidikan dan Kebudayaan Riset dan Teknologi Indonesia pada tahun 2017, 2020, 2021, dan 2022, serta hibah internasional dari International Society of Travel Medicine (ISTM) pada tahun 2016 dan 2021.

Peran di Jurnal Ilmiah

·         Reviewer: Dr. Dewa Ayu sering diundang untuk melakukan review artikel pada jurnal internasional, memberikan kontribusi penting dalam proses evaluasi dan publikasi ilmiah.

Komitmen Sosial

Dr. Dewa Ayu berkomitmen untuk meningkatkan kesadaran masyarakat mengenai penyakit tropis dan infeksi, serta aktif dalam program-program pengabdian masyarakat yang bertujuan untuk meningkatkan kesehatan masyarakat di Indonesia.

Dengan pengalaman dan dedikasi yang tinggi, Dr. Dewa Ayu Putri Sri Masyeni berupaya untuk terus berkontribusi dalam bidang kedokteran, penelitian, dan pendidikan, serta memberikan dampak positif bagi masyarakat dan dunia kesehatan.

 

Referensi

1. Harran E, Hilan C, Djelouadji Z, Ayral F. Epidemiology of Leptospirosis: The First Literature Review of the Neglected Disease in the Middle East. Trop Med Infect Dis. 2022;7(10):260. doi:10.3390/tropicalmed7100260

2. Costa F, Hagan JE, Calcagno J, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. Small PLC, ed. PLoS Negl Trop Dis. 2015;9(9):e0003898. doi:10.1371/journal.pntd.0003898

3. Torgerson PR, Hagan JE, Costa F, et al. Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years. Small PLC, ed. PLoS Negl Trop Dis. 2015;9(10):e0004122. doi:10.1371/journal.pntd.0004122

4. Murillo A, Goris M, Ahmed A, Cuenca R, Pastor J. Leptospirosis in cats: Current literature review to guide diagnosis and management. J Feline Med Surg. 2020;22(3):216-228. doi:10.1177/1098612X20903601

5. Widjajanti W. Epidemiologi, diagnosis, dan pencegahan Leptospirosis Epidemiology, diagnosis, and prevention of Leptospirosis. J Heal Epidemiol Commun Deseases. 2020;5(2):62-68.

6. Thibeaux R, Girault D, Bierque E, et al. Biodiversity of Environmental Leptospira: Improving Identification and Revisiting the Diagnosis. Front Microbiol. 2018;9. doi:10.3389/fmicb.2018.00816

7. Nakamura S. Measurement of the Cell-Body Rotation of Leptospira. In: ; 2020:139-148. doi:10.1007/978-1-0716-0459-5_13

8. Adler B, de la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol. 2010;140(3-4):287-296. doi:10.1016/j.vetmic.2009.03.012

9. Haake DA, Zückert WR. The Leptospiral Outer Membrane. In: ; 2015:187-221. doi:10.1007/978-3-662-45059-8_8

10. Fraga TR, Barbosa AS, Isaac L. Leptospirosis: Aspects of Innate Immunity, Immunopathogenesis and Immune Evasion From the Complement System. Scand J Immunol. 2011;73(5):408-419. doi:10.1111/j.1365-3083.2010.0250 5.x

11. Akira S, Uematsu S, Takeuchi O. Pathogen Recognition and Innate Immunity. Cell. 2006;124(4):783-801. doi:10.1016 /j.cell.2006.02.015

12. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol. 2005;3(1):36-46. doi:10.1038/nrmicro1068

13. Petakh P, Isevych V, Kamyshnyi A, Oksenych V. Weil’s Disease Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota. Biomolecules. 2022;12(12):1830. doi:10.3390/biom12121830

14. Que-Gewirth NLS, Ribeiro AA, Kalb SR, et al. A Methylated Phosphate Group and Four Amide-linked Acyl Chains in Leptospira interrogans Lipid A. J Biol Chem. 2004;279(24):25420-25429. doi:10.1074/jbc.M400598200

15. Nahori MA, Fournié-Amazouz E, Que-Gewirth NS, et al. Differential TLR Recognition of Leptospiral Lipid A and Lipopolysaccharide in Murine and Human Cells. J Immunol. 2005;175(9):6022-6031. doi:10.4049/jimmunol.175.9.6022

16. Geijtenbeek TBH, Van Kooyk Y. Pathogens target DC‐SIGN to influence their fate DC‐SIGN functions as a pathogen receptor with broad specificity. APMIS. 2003;111(7-8):698-714. doi:10.1034/j.1600-0463.2003.11107803.x

17. Urban CF, Lourido S, Zychlinsky A. How do microbes evade neutrophil killing? Cell Microbiol. 2006;8(11):1687-1696. doi:10.1111/j.1462-5822.2006.00792.x

18. Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta - Mol Cell Res. 2014;1843(11):2563-2582. doi:10.1016/j.bbamcr.2014.05.014

19. Wink DA, Hines HB, Cheng RYS, et al. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol. 2011;89(6):873-891. doi:10.1189/jlb.1010550

20. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the Eye of the Cytokine Storm. Microbiol Mol Biol Rev. 2012;76(1):16-32. doi:10.1128/MMBR.05015-11

21. Gaudart N, Ekpo P, Pattanapanyasat K, van Kooyk Y, Engering A. Leptospira interrogans is recognized through DC-SIGN and induces maturation and cytokine production by human dendritic cells. FEMS Immunol Med Microbiol. 2008;53(3):359-367. doi:10.1111/j.1574-695X.2008.0043 7.x

22. Yang CW. Leptospirosis renal disease: Understanding the initiation by Toll-like receptors. Kidney Int. 2007;72(8):918-925. doi:10.1038/sj.ki.5002393

23. Zhao H qiang, Li W min, Lu Z qiu, Sheng Z yong, Yao Y ming. The Growing Spectrum of Anti-Inflammatory Interleukins and Their Potential Roles in the Development of Sepsis. J Interf Cytokine Res. 2015;35(4):242-251. doi:10.1089 /jir.2014.0119

24. Estavoyer JM, Racadot E, Couetdic G, Leroy J, Grosperrin L. Tumor Necrosis Factor in Patients with Leptospirosis. Clin Infect Dis. 1991;13(6):1245-1245. doi:10.1093/clinids /13.6. 1245

25. Mikulski M, Boisier P, Lacassin F, et al. Severity markers in severe leptospirosis: a cohort study. Eur J Clin Microbiol Infect Dis. 2015;34(4):687-695. doi:10.1007/s10096-014-2275-8

26. Reis EAG, Hagan JE, Ribeiro GS, et al. Cytokine Response Signatures in Disease Progression and Development of Severe Clinical Outcomes for Leptospirosis. Coburn J, ed. PLoS Negl Trop Dis. 2013;7(9):e2457. doi:10.1371/journal .pntd.0002 457

27. Chirathaworn C, Supputtamongkol Y, Lertmaharit S, Poovorawan Y. Cytokine levels as biomarkers for leptospirosis patients. Cytokine. 2016;85:80-82. doi:10.101 6/j.cyto.201 6.06.007

28. Wagenaar JFP, Gasem MH, Goris MGA, et al. Soluble ST2 Levels Are Associated with Bleeding in Patients with Severe Leptospirosis. Peacock SJ, ed. PLoS Negl Trop Dis. 2009;3(6):e453. doi:10.1371/journal.pntd.0000453

29. Fialho RN, Martins L, Pinheiro JP, et al. Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis. Hum Immunol. 2009;70(11):915-920. doi:10.1016/j.humimm.2009.08.007

30. Matsui M, Roche L, Geroult S, et al. Cytokine and Chemokine Expression in Kidneys during Chronic Leptospirosis in Reservoir and Susceptible Animal Models. Wooten RM, ed. PLoS One. 2016;11(5):e0156084. doi: 10.1371/journal .pone.0156084

31. Del Carlo Bernardi F, Ctenas B, da Silva LFF, et al. Immune receptors and adhesion molecules in human pulmonary leptospirosis. Hum Pathol. 2012;43(10):1601-1610. doi:10.1016/j.humpath.2011.11.017

32. Wagenaar JFP, Goris MGA, Gasem MH, et al. Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect. 2009;58(6):425-432. doi:10.1016/j.jinf.2009.04.004

33. VK C, TY L, WF L, et al. Leptospirosis in human: Biomarkers in host immune responses. Microbiol Res. 2018;207:108-115. doi:10.1016/j.micres.2017.11.015

34. Zhang C, Xu J, Zhang T, et al. Genetic characteristics of pathogenic Leptospira in wild small animals and livestock in Jiangxi Province, China, 2002–2015. Lin T, ed. PLoS Negl Trop Dis. 2019;13(6):e0007513. doi: 10.1371/journal .pntd.0007513

35. Esteves LM, Bulhões SM, Branco CC, et al. Human Leptospirosis: Seroreactivity and Genetic Susceptibility in the Population of São Miguel Island (Azores, Portugal). Dellagostin OA, ed. PLoS One. 2014;9(9):e108534. doi:10.1371/journal.pone.0108534

36. Cédola M, Chiani Y, Pretre G, Alberdi L, Vanasco B, Gómez RM. Association of Toll-like receptor 2 Arg753Gln and Toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an argentine population. Acta Trop. 21015;146:73-80. doi:10.1016/j.actatropic2a.2015.03.0307

37. Murgia R, Garcia R, Cinco M. Leptospires Are Killed In Vitro by Both Oxygen-Dependent and -Independent Reactions. Infect Immun. 2002;70(12):7172-7175. doi:10 .1128/IAI.70.12.7 172-7175.2002

38. Vieira ML, Teixeira AF, Pidde G, et al. Leptospira interrogans outer membrane protein LipL21 is a potent inhibitor of neutrophil myeloperoxidase. Virulence. 2018;9(1):414-425. doi:10.1080/21505594.2017.1407484

39. Santecchia I, Ferrer MF, Vieira ML, Gómez RM, Werts C. Phagocyte Escape of Leptospira: The Role of TLRs and NLRs. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.571816

40. Scharrig E, Carestia A, Ferrer MF, et al. Neutrophil Extracellular Traps are Involved in the Innate Immune Response to Infection with Leptospira. Vinetz JM, ed. PLoS Negl Trop Dis. 2015;9(7):e0003927. doi: 10.1371/journal .pntd.0003927

41. Zipfel PF, Würzner R, Skerka C. Complement evasion of pathogens: Common strategies are shared by diverse organisms. Mol Immunol. 2007;44(16):3850-3857. Doi :10.1016/j.molimm.2007.06.149

42. Choy HA. Multiple Activities of LigB Potentiate Virulence of Leptospira interrogans: Inhibition of Alternative and Classical Pathways of Complement. Stevenson B, ed. PLoS One. 2012;7(7):e41566. doi: z10.1371/journal.pone .0041566

43. Souza NM, Vieira ML, Alves IJ, de Morais ZM, Vasconcellos SA, Nascimento ALTO. Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp. Microb Pathog. 2012;53(3-4):125-134. doi:10.1016/j.micpath.2012.06.001

44. Domingos RF, Vieira ML, Romero EC, et al. Features of two proteins of Leptospira interrogans with potential role in host-pathogen interactions. BMC Microbiol. 2012;12(1):50. doi:10.1186/1471-2180-12-50

45. Barbosa AS, Monaris D, Silva LB, et al. Functional Characterization of LcpA, a Surface-Exposed Protein of Leptospira spp. That Binds the Human Complement Regulator C4BP. Infect Immun. 2010;78(7):3207-3216. doi:10.1128/IAI.00279-10

46. Yang CW, Wu MS, Pan MJ, Hsieh WJ, Vandewalle A, Huang CC. The Leptospira Outer Membrane Protein LipL32 Induces Tubulointerstitial Nephritis-Mediated Gene Expression in Mouse Proximal Tubule Cells. J Am Soc Nephrol. 2002;13(8):2037-2045. doi:10.1097/01.ASN.0000022007 .91733.62

47. Ondee T, Gillen J, Visitchanakun P, et al. Lipocalin-2 (Lcn-2) Attenuates Polymicrobial Sepsis with LPS Preconditioning (LPS Tolerance) in FcGRIIb Deficient Lupus Mice. Cells. 2019;8(9):1064. doi:10.3390/cells8091064

48. YANG CW, WU MS, PAN MJ, et al. Leptospira Outer Membrane Protein Activates NF-κB and Downstream Genes Expressed in Medullary Thick Ascending Limb Cells. J Am Soc Nephrol. 2000;11(11):2017-2026. doi:10.1681/ASN.V11112017

49. Haake DA, Chao G, Zuerner RL, et al. The Leptospiral Major Outer Membrane Protein LipL32 Is a Lipoprotein Expressed during Mammalian Infection. Orndorff PE, ed. Infect Immun. 2000;68(4):2276-2285. doi:10.1128/IAI.68.4.2276-2285. 2000

50. Lee SH, Kim KA, Park YG, Seong IW, Kim MJ, Lee YJ. Identification and partial characterization of a novel hemolysin from Leptospira interrogans serovar lai. Gene. 2000;254(1-2):19-28. doi:10.1016/S0378-1119(00)00293-

51. Li S, Wang M, Ojcius DM, et al. Leptospira interrogans infection leads to IL-1β and IL-18 secretion from a human macrophage cell line through reactive oxygen species and cathepsin B mediated-NLRP3 inflammasome activation. Microbes Infect. 2018;20(4):254-260. doi:10.1016/j.micinf. 2018.01.010

52. Wang H, Wu Y, Ojcius DM, et al. Leptospiral Hemolysins Induce Proinflammatory Cytokines through Toll-Like Receptor 2-and 4-Mediated JNK and NF-κB Signaling Pathways. Giambartolomei GH, ed. PLoS One. 2012;7(8):e42266. doi:10.1371/journal.pone.0042266

53. Gonçalves-de-Albuquerque CF, Burth P, Silva AR, Younes-Ibrahim M, Castro-Faria-Neto HC, Castro-Faria MV. Leptospira and Inflammation. Mediators Inflamm. 2012;2012:1-11. doi:10.1155/2012/317950

54. Segura ER, Ganoza CA, Campos K, et al. Clinical Spectrum of Pulmonary Involvement in Leptospirosis in a Region of Endemicity, with Quantification of Leptospiral Burden. Clin Infect Dis. 2005;40(3):343-351. doi:10.1086/427110

55. Gouveia EL, Metcalfe J, de Carvalho ALF, et al. Leptospirosis-associated Severe Pulmonary Hemorrhagic Syndrome, Salvador, Brazil. Emerg Infect Dis. 2008;14(3):505-508. doi:10.3201/eid1403.071064

56. Bulach DM, Zuerner RL, Wilson P, et al. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci. 2006;103(39):14560-14565. doi:10.1073/pnas.0603979103

57. Ren SX, Fu G, Jiang XG, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature. 2003;422(6934):888-893. doi:10.1038/nature01597

58. Silva JJP da, Dalston MO, Carvalho JEM de, Setúbal S, Oliveira JMC de, Pereira MM. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop. 2002;35(4):395-399. doi:10.1590/S0037-8682200200040 0017

59. Seguro AC, Andrade L. Pathophysiology of Leptospirosis. Shock. 2013;39(Supplement 1):17-23. doi:10.1097/SHK .0b013e31828fae49

60. Andrade L, Rodrigues AC, Sanches TRC, Souza RB, Seguro AC. Leptospirosis leads to dysregulation of sodium transporters in the kidney and lung. Am J Physiol Physiol. 2007;292(2):F586-F592. doi:10.1152/ajprenal.00102.2006

61. Vieira ML, Naudin C, Mörgelin M, Romero EC, Nascimento ALTO, Herwald H. Modulation of Hemostatic and Inflammatory Responses by Leptospira Spp. Ricaldi JN, ed. PLoS Negl Trop Dis. 2016;10(5):e0004713. doi:10.1371 /journal.pntd.0004713

62. Wagenaar JFP, Goris MGA, Partiningrum DL, et al. Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Heal. 2010;15(2):152-159. doi:10.1111/j.1365-3156.2009.02434.x

63. Evangelista K, Franco R, Schwab A, Coburn J. Leptospira interrogans Binds to Cadherins. Lukehart S, ed. PLoS Negl Trop Dis. 2014;8(1):e2672. doi:10.1371/journal. pntd.0002672

64. Kochi LT, Fernandes LGV., Souza GO, et al. The interaction of two novel putative proteins of Leptospira interrogans with E-cadherin, plasminogen and complement components with potential role in bacterial infection. Virulence. 2019;10(1):734-753. doi:10.1080/21505594.2019. 1650 613

65. De Brito T, Silva AMG da, Abreu PAE. Pathology and pathogenesis of human leptospirosis: a commented review. Rev Inst Med Trop Sao Paulo. 2018;60. doi:10.1590/s1678-9946201860023

66. Vieira ML, Fernandes LG, Domingos RF, et al. Leptospiral extracellular matrix adhesins as mediators of pathogen-host interactions. FEMS Microbiol Lett. 2014;352(2):129-139. doi:10.1111/1574-6968.12349

67. Hobby GP, Karaduta O, Dusio GF, Singh M, Zybailov BL, Arthur JM. Chronic kidney disease and the gut microbiome. Am J Physiol Physiol. 2019;316(6):F1211-F1217. doi:10.1152/ajprenal.00298.2018

68. Al Khodor S, Shatat IF. Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol. 2017;32(6):921-931. doi:10.1007/s00467-016-3392-7

69. Lin CY. Leptospirosis-Associated Acute Kidney Injury. In: Karger. ; 2019:20-26. doi:10.1159/000500379

70. Stavropoulou E, Kantartzi K, Tsigalou C, et al. Focus on the Gut–Kidney Axis in Health and Disease. Front Med. 2021;7. doi:10.3389/fmed.2020.620102

71. Chou YT, Kan WC, Shiao CC. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment. Int J Mol Sci. 2022;23(7):3658. doi:10.3390/ ijms23073658

72. Ohtani N, Kawada N. Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship. Hepatol Commun. 2019;3(4):456-470. doi:10.1002/hep4.1331

73. Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558-577. doi:10.1016/j.jhep.2019.10.003

74. Zheng Z, Wang B. The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration. Front Immunol. 2021;12. doi:10.3389/ fimmu.2021.775526

75. Tokuhara D. Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. Front Nutr. 2021;8. doi:10.3389/fnut.2021.700058

76. Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. J Hepatol. 2020;72(5):1003-1027. doi:10.1016/j.jhep.20 20.01.017

77. Cornell RP, Liljequist BL, Bartizal KF. Depressed Liver Regeneration After Partial Hepatectomy of Germ–Free, Athymic and Lipopolysaccharide–Resistant Mice. Hepatology. 1990;11(6):916-922. doi:10.1002/hep.1 840110603

78. Garrett WS. Immune recognition of microbial metabolites. Nat Rev Immunol. 2020;20(2):91-92. doi:10.1038/s41577-019-0252-2

79. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5(10):836-847. doi:10.1038/ nrm1489

80. Wang HB, Wang PY, Wang X, Wan YL, Liu YC. Butyrate Enhances Intestinal Epithelial Barrier Function via Up-Regulation of Tight Junction Protein Claudin-1 Transcription. Dig Dis Sci. 2012;57(12):3126-3135. doi:10.1007/s10620-012-2259-4

81. Liu B, Qian J, Wang Q, Wang F, Ma Z, Qiao Y. Butyrate Protects Rat Liver against Total Hepatic Ischemia Reperfusion Injury with Bowel Congestion. Bruns H, ed. PLoS One. 2014;9(8):e106184. doi:10.1371/journal.pone.0106184

82. Dumas A, Bernard L, Poquet Y, Lugo-Villarino G, Neyrolles O. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Cell Microbiol. 2018;20(12):e12966. doi:10.1111/cmi.12966

83. Dang AT, Marsland BJ. Microbes, metabolites, and the gut–lung axis. Mucosal Immunol. 2019;12(4):843-850. doi:10.1038/s41385-019-0160-6

84. Taylor SL, Wesselingh S, Rogers GB. Host-microbiome interactions in acute and chronic respiratory infections. Cell Microbiol. 2016;18(5):652-662. doi:10.1111/cmi.12589

85. Gauguet S, D’Ortona S, Ahnger-Pier K, et al. Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia. McCormick BA, ed. Infect Immun. 2015;83(10):4003-4014. doi:10.1128/IAI.00037-15

86. Bruzzese E, Callegari ML, Raia V, et al. Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial. Bereswill S, ed. PLoS One. 2014;9(2):e87796. doi:10.1371/journal.pone.0087796

87. Ranucci G, Buccigrossi V, Freitas MB de, Guarino A, Giannattasio A. Early-Life Intestine Microbiota and Lung Health in Children. J Immunol Res. 2017;2017:1-5. doi:10.1155/2017/8450496

88. Zhou D, Wang Q, Liu H. Coronavirus disease 2019 and the gut–lung axis. Int J Infect Dis. 2021;113:300-307. doi:10.1016/j.ijid.2021.09.013

89. Xie X, Liu J, Chen X, et al. Gut microbiota involved in leptospiral infections. ISME J. 2022;16(3):764-773. doi:10.1038/s41396-021-01122-6

90. Becattini S, Sorbara MT, Kim SG, et al. Rapid transcriptional and metabolic adaptation of intestinal microbes to host immune activation. Cell Host Microbe. 2021;29(3):378-393.e5. doi:10.1016/j.chom.2021.01.003

91. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341-352. doi:10.1038/nri.2016.42

92. Akhtar T, Naeem MI, Younus M, Un Nisa Q, Ahmad HM. Dog-mediated Leptospirosis. Int J Agric Biosci. 2023;(Zoonosis Volume 4):356-368. doi:10.47278/book.zoon/2023.161

93. Limothai U, Srisawat N, Haake DA. Early Diagnosis and Treatment of Leptospirosis: Optimizing Clinical Outcomes. J Infect. 2026:106675. doi:10.1016/j.jinf.2025.106675

94. Haake DA, Levett PN. Leptospirosis in Humans. Curr Top Microbiol Immunol. 2015;387:65-97. doi:10.1007/978-3-662-45059-8_5

95. Haake DA, Dundoo M, Cader R, et al. Leptospirosis, Water Sports, and Chemoprophylaxis. Clin Infect Dis. 2002;34(9):e40-e43. doi:10.1086/339942

96. Monahan AM, Miller IS, Nally JE. Leptospirosis: risks during recreational activities. J Appl Microbiol. 2009;107(3):707-716. doi:10.1111/j.1365-2672.2009.04220.x

97. Kumar SS. Indian Guidelines for the Diagnosis and Management of Human Leptospirosis. In: The Association of Physicians of India: Mumbai, India. ; 2013:23-29.

98. World Health Organization. Human Leptospirosis: guidance for diagnosis, surveillance and control. Published online 2003.

99. Sykes JE, Reagan KL, Nally JE, Galloway RL, Haake DA. Role of Diagnostics in Epidemiology, Management, Surveillance, and Control of Leptospirosis. Pathogens. 2022;11(4):395. doi:10.3390/pathogens11040395

100. Agampodi SB, Matthias MA, Moreno AC, Vinetz JM. Utility of Quantitative Polymerase Chain Reaction in Leptospirosis Diagnosis: Association of Level of Leptospiremia and Clinical Manifestations in Sri Lanka. Clin Infect Dis. 2012;54(9):1249-1255. doi:10.1093/cid/cis035

101. Chierakul W, Tientadakul P, Suputtamongkol Y, et al. Activation of the Coagulation Cascade in Patients with Leptospirosis. Clin Infect Dis. 2008;46(2):254-260. doi:10.1086/524664

102. Wangrangsimakul T, Althaus T, Mukaka M, et al. Causes of acute undifferentiated fever and the utility of biomarkers in Chiangrai, northern Thailand. Marks F, ed. PLoS Negl Trop Dis. 2018;12(5):e0006477. doi:10.1371/journal.pntd.0006477

103. Tillekeratne LG, Suchindran S, Ko ER, et al. Previously Derived Host Gene Expression Classifiers Identify Bacterial and Viral Etiologies of Acute Febrile Respiratory Illness in a South Asian Population. Open Forum Infect Dis. 2020;7(6). doi:10.1093/ofid/ofaa194

104. Le Turnier P, Bonifay T, Mosnier E, et al. Usefulness of C-Reactive Protein in Differentiating Acute Leptospirosis and Dengue Fever in French Guiana. Open Forum Infect Dis. 2019;6(9). doi:10.1093/ofid/ofz323

105. Crouzet J, Faucher JF, Toubin M, Hoen B, Estavoyer JM. Serum C-reactive protein (CRP) and procalcitonin (PCT) levels and kinetics in patients with leptospirosis. Eur J Clin Microbiol Infect Dis. 2011;30(2):299-302. doi:10.1007/s10096-010-1088-7

106. Lindow JC, Wunder EA, Popper SJ, et al. Cathelicidin Insufficiency in Patients with Fatal Leptospirosis. Samuels DS, ed. PLOS Pathog. 2016;12(11):e1005943. doi:10.1371/ journal.ppat.1005943

107. Murray CK, Gray MR, Mende K, et al. Use of patient-specific Leptospira isolates in the diagnosis of leptospirosis employing microscopic agglutination testing (MAT). Trans R Soc Trop Med Hyg. 2011;105(4):209-213. doi:10.1016/ j.trstmh.2010.12.004

108. Picardeau M, Bertherat E, Jancloes M, Skouloudis AN, Durski K, Hartskeerl RA. Rapid tests for diagnosis of leptospirosis: Current tools and emerging technologies. Diagn Microbiol Infect Dis. 2014;78(1):1-8. doi:10.1016/j.diagmicrobio .2013.09.012

109. Lessa-Aquino C, Borges Rodrigues C, Pablo J, et al. Identification of Seroreactive Proteins of Leptospira interrogans Serovar Copenhageni Using a High-Density Protein Microarray Approach. Small PLC, ed. PLoS Negl Trop Dis. 2013;7(10):e2499. doi:10.1371/journal.pntd.0002499

110. McBride AJA, Cerqueira GM, Suchard MA, et al. Genetic diversity of the Leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol. 2009;9(2):196-205. doi:10.1016/j.meegid.2008.10.012

111. Dawson P, Marfel M, Galloway R, et al. Notes from the Field: Interpretation of Rapid Diagnostic Tests for Leptospirosis During a Dengue Outbreak Yap State, Federated States of Micronesia, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(48):1832-1833. doi:10.15585/mmwr.mm6948a6

112. Hornsby RL, Alt DP, Nally JE. Isolation and propagation of leptospires at 37 °C directly from the mammalian host. Sci Rep. 2020;10(1):9620. doi:10.1038/s41598-020-66526-4

113. Narkkul U, Thaipadungpanit J, Srilohasin P, et al. Optimization of Culture Protocols to Isolate Leptospira spp. from Environmental Water, Field Investigation, and Identification of Factors Associated with the Presence of Leptospira spp. in the Environment. Trop Med Infect Dis. 2020;5(2):94. doi:10.3390/tropicalmed5020094

114. Zarantonelli L, Suanes A, Meny P, et al. Isolation of pathogenic Leptospira strains from naturally infected cattle in Uruguay reveals high serovar diversity, and uncovers a relevant risk for human leptospirosis. Coburn J, ed. PLoS Negl Trop Dis. 2018;12(9):e0006694. doi:10.1371/journal.pntd.0006694

115. Miller DA, Wilson MA, Beran GW. The Effect of Storage Time on Isolation of Leptospira Interrogans from Bovine Kidneys. J Vet Diagnostic Investig. 1990;2(1):63-65. doi:10.1177/ 104063879000200112

116. Ho HF, Blackmore DK. Effect of chilling and freezing on survival of Leptospira interrogans serovar pomona in naturally infected pig kidneys. N Z Vet J. 1979;27(6):121-123. doi:10.1080/00480169.1979.34622

117. Cranford HM, Browne AS, LeCount K, et al. Mongooses (Urva auropunctata) as reservoir hosts of Leptospira species in the United States Virgin Islands, 2019–2020. Neela V kumari, ed. PLoS Negl Trop Dis. 2021;15(11):e0009859. doi:10.1371/journal.pntd.0009859

118. Md EM, Vetd FM, Pesenti L, PhD DSM, Md GA, PhD PPM. Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific). Aust N Z J Ophthalmol. 1999;27(6):380-386. doi:10.1046/j.1440-1606.1999.00269.x

119. Yang B, de Vries SG, Visser BJ, et al. Molecular and antigen detection tests for leptospirosis. Cochrane Database Syst Rev. 2015. doi:10.1002/14651858.CD011871

120. Chiriboga J, Barragan V, Arroyo G, et al. High Prevalence of Intermediate Leptospira spp. DNA in Febrile Humans from Urban and Rural Ecuador. Emerg Infect Dis. 2015;21(12):2141-2147. doi:10.3201/eid2112.140659

121. Puche R, Ferrés I, Caraballo L, et al. Leptospira venezuelensis sp. nov., a new member of the intermediate group isolated from rodents, cattle and humans. Int J Syst Evol Microbiol. 2018;68(2):513-517. doi:10.1099/ijsem.0.002528

122. Levett PN, Morey RE, Galloway RL, Steigerwalt AG. Leptospira broomii sp. nov., isolated from humans with leptospirosis. Int J Syst Evol Microbiol. 2006;56(3):671-673. doi:10.1099/ijs.0.63783-0

123. Vincent AT, Schiettekatte O, Goarant C, et al. Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics. Martins EAL, ed. PLoS Negl Trop Dis. 2019;13(5):e0007270. doi:10.1371/ journal.pntd.0007270

124. Schürch AC, Arredondo-Alonso S, Willems RJL, Goering RV. Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene–based approaches. Clin Microbiol Infect. 2018;24(4):350-354. doi:10.1016/ j.cmi.2017.12.016

125. Guglielmini J, Bourhy P, Schiettekatte O, Zinini F, Brisse S, Picardeau M. Genus-wide Leptospira core genome multilocus sequence typing for strain taxonomy and global surveillance. Lin T, ed. PLoS Negl Trop Dis. 2019;13(4):e0007374. doi:10.1371/journal.pntd.0007374

126. Brenner DJ, Kaufmann AF, Sulzer KR, Steigerwalt AG, Rogers FC, Weyant RS. Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp. nov. and four new Leptospira genomospecies. Int J Syst Evol Microbiol. 1999;49(2):839-858. doi:10.1099/00207713-49-2-839

127. Kmety E, Dikken H. Classification of the Species Leptospira Interrogans and History of Its Serovars; 1993.

128. Fornazari F, Richini-Pereira VB, Joaquim SF, Nachtigall PG, Langoni H. Leptospirosis diagnosis among patients suspected of dengue fever in Brazil. J Venom Anim Toxins Incl Trop Dis. 2021;27. doi:10.1590/1678-9199-jvatitd-2020-0118

129. Ittyachen AM. Covid-19 and leptospirosis: Cytokine storm and the use of steroids. Trop Doct. 2021;51(1):128-130. doi:10.1177/0049475520971425

130. Zaki S, Shieh W. Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. Lancet. 1996;347(9000):535-536.

131. Romero EC, Billerbeck AEC, Lando VS, Camargo ED, Souza CC, Yasuda PH. Detection of Leptospira DNA in Patients with Aseptic Meningitis by PCR. J Clin Microbiol. 1998;36(5):1453-1455. doi:10.1128/JCM.36.5.1453-1455. 1998

132. Wilson MR, Naccache SN, Samayoa E, et al. Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing. N Engl J Med. 2014;370(25):2408-2417. doi:10.1056/NEJMoa1401268

133. Dircio Montes Sergio A, González Figueroa E, María Saadia VG, et al. Leptospirosis Prevalence in Patients with Initial Diagnosis of Dengue. J Trop Med. 2012;2012:1-5. doi:10.115 5/ 2012/519701

134. Nhan TX, Bonnieux E, Rovery C, De Pina JJ, Musso D. Fatal leptospirosis and chikungunya co-infection: Do not forget leptospirosis during chikungunya outbreaks. IDCases. 2016;5:12-14. doi:10.1016/j.idcr.2016.06.003

135. del Valle-Mendoza J, Palomares-Reyes C, Carrillo-Ng H, et al. Leptospirosis in febrile patients with suspected diagnosis of dengue fever. BMC Res Notes. 2021;14(1):209. doi:10.118 6/s13104-021-05627-3

136. Niriella MA, Ediriweera DS, De Silva AP, Premarathna BHR, Jayasinghe S, de Silva HJ. Dengue and leptospirosis infection during the coronavirus 2019 outbreak in Sri Lanka. Trans R Soc Trop Med Hyg. 2021;115(9):944-946. doi:10.1093 /trstmh/trab058

137. Krol P, Coolen‐Allou N, Teysseyre L, et al. Differential diagnoses of severe COVID‐19 in tropical areas: the experience of Reunion Island. Trop Med Int Heal. 2021;26(4):444-452. doi:10.1111/tmi.13542

138. Conroy AL, Gélvez M, Hawkes M, et al. Host biomarkers distinguish dengue from leptospirosis in Colombia: a case–control study. BMC Infect Dis. 2014;14(1):35. doi:10.1186/1471-2334-14-35

139. Michels M, de Mast Q, Netea MG, et al. Normal Free Interleukin-18 (IL-18) Plasma Levels in Dengue Virus Infection and the Need To Measure Both Total IL-18 and IL-18 Binding Protein Levels. Rosenberg HF, ed. Clin Vaccine Immunol. 2015;22(6):650-655. doi:10.1128/CVI.00147-15

140. Ko ER, Reller ME, Tillekeratne LG, et al. Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance. Sci Rep. 2023;13(1):22554. doi:10.1038/s41598-023-49734-6

141. Iglesias-Ussel MD, O’Grady N, Anderson J, et al. A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform. Open Forum Infect Dis. 2024;12(1).

LEPTOSPIROSIS : EPIDEMIOLOGI, MIKROBIOLOGI, DAN MANAJEMEN KLINIS

Unduhan

PREVIEW
PREVIEW

Diterbitkan

4 Februari 2026
Hak Cipta (c) 2026 Dewa Ayu Putri Sri Masyeni (Author)

Lisensi

Creative Commons License

Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.

Detail format terbitan yang tersedia: PREVIEW

PREVIEW

ISBN-13 (15)

EPIDEMIOLOGI, MIKROBIOLOGI, DAN MANAJEMEN KLINIS

Dimensi Fisik

Detail format terbitan yang tersedia: PREVIEW

PREVIEW

ISBN-13 (15)

EPIDEMIOLOGI, MIKROBIOLOGI, DAN MANAJEMEN KLINIS

Cara Mengutip

LEPTOSPIROSIS: EPIDEMIOLOGI, MIKROBIOLOGI, DAN MANAJEMEN KLINIS. (2026). PENERBIT KARYA BAKTI MAKMUR (KBM) INDONESIA. https://librarypenerbitkbm.science/index.php/buku/catalog/book/1003